Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results
[at noodls] – VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold … more
View todays social media effects on TKMR
View the latest stocks trending across Twitter. Click to view dashboard
See who Tekmira is hiring next, click here to view
